TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | -2 | 2 | 5 | 9 | 21 | 6 | 7 |
| P | %wins | 50 | 100 | 100 | 100 | 50 | 50 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/27/13 16:56 | 9/25/13 | BIND | Bind Therapeutics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Flagship Ventures Fund 2004 L P | MA | T | P.d | 300 | 15.00 | 9 | 20 | 1 | 1,563 | I | 3 | -4 | 2 | 2 | 5 | -18 | -40 | ||||||||
3/27/13 20:17 | 3/25/13 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Flagship Ventures Fund 2004 L P | MA | T | P.d | 3,443 | 7.00 | 3 | 492 | 73 | 1,166 | D | -1 | 1 | 2 | 7 | 12 | 60 | 51 | ||||||||
9/22/09 19:51 | 9/18/09 | HLCS | Helicos Biosciences Corp | Health | Drug | Pharmaceutical Preparations | Flagship Ventures Fund 2004 L P | MA | DT | P.d | 0 | 0.00 | 0 | 243 | 2 | 12,193 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |